litlas
Log inCreate account

Markku Miettinen

Active 1982–2025

273
Papers
56,003
Citations
128
h-index
266
i10-index

Citations

Citations per year for Markku Miettinen1979: 1 citations1980: 1 citations1981: 1 citations1982: 3 citations1983: 15 citations1984: 34 citations1985: 49 citations1986: 54 citations1987: 43 citations1988: 39 citations1989: 22 citations1990: 30 citations1991: 36 citations1992: 23 citations1993: 40 citations1994: 20 citations1995: 30 citations1996: 52 citations1997: 60 citations1998: 80 citations1999: 120 citations2000: 172 citations2001: 284 citations2002: 355 citations2003: 381 citations2004: 332 citations2005: 382 citations2006: 395 citations2007: 286 citations2008: 353 citations2009: 275 citations2010: 232 citations2011: 261 citations2012: 216 citations2013: 191 citations2014: 263 citations2015: 188 citations2016: 193 citations2017: 242 citations2018: 144 citations2019: 781 citations2020: 835 citations2021: 726 citations2022: 516 citations2023: 385 citations2024: 627 citations2025: 254 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,946 citing papers, 31.9% of this breakdownChina: 626 citing papers, 6.8% of this breakdownGermany: 543 citing papers, 5.9% of this breakdownUnited Kingdom: 523 citing papers, 5.7% of this breakdownItaly: 513 citing papers, 5.5% of this breakdownJapan: 421 citing papers, 4.6% of this breakdownFrance: 393 citing papers, 4.2% of this breakdownCanada: 323 citing papers, 3.5% of this breakdownNetherlands: 242 citing papers, 2.6% of this breakdownSpain: 227 citing papers, 2.5% of this breakdownSwitzerland: 202 citing papers, 2.2% of this breakdownAustralia: 200 citing papers, 2.2% of this breakdown
0%31.9%Other 22.4%

Institutions

Fields

  • Medicine77.7%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Immunology and Microbiology3.4%
  • Computer Science1.9%
  • Engineering0.6%
  • Neuroscience0.5%
  • Other1.1%

Topics

  • Sarcoma Diagnosis and Treatment7.4%
  • Gastrointestinal Tumor Research and Treatment6.3%
  • Gastrointestinal disorders and treatments3.3%
  • Neurofibromatosis and Schwannoma Cases2.7%
  • Soft tissue tumor case studies2.4%
  • Vascular Tumors and Angiosarcomas1.9%
  • Other76%

Coauthors

All papers

Open in search
  1. Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers

    Authors: Song Qu, Patricia Fetsch, Anish Thomas, Yves Pommier, David S. Schrump, Markku Miettinen, Haobin Chen - Journal of Thoracic Oncology 2021 cited by 150

  2. KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis

    Authors: Meera Murgai, Wei Ju, Matthew G. Eason, Jessica Kline, Daniel W. Beury, Sabina Kaczanowska, Markku Miettinen, Michael J. Kruhlak, Haiyan Lei, Jack F. Shern, Olga A. Cherepanova, Gary K. Owens, Rosandra N. Kaplan - Nature Medicine 2017 cited by 290

  3. The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation

    Authors: Andrew S. Brohl, David A. Solomon, Wendy Chang, Jianjun Wang, Young Song, Sivasish Sindiri, Rajesh Patidar, Laura Hurd, Li Chen, Jack F. Shern, Hongling Liao, Xinyu Wen, Julia Gerard, Jung‐Sik Kim, José Antonio López Guerrero, Isidro Machado, Daniel Wai, Piero Picci, Timothy J. Triche, Andrew Horvai, Markku Miettinen, Jun S. Wei, Daniel Catchpool, Antonio Llombart‐Bosch, Todd Waldman, Javed Khan - PLoS Genetics 2014 cited by 453

  4. Gastrointestinal stromal tumors: Pathology and prognosis at different sites

    Authors: Markku Miettinen, Jerzy Lasota - Seminars in Diagnostic Pathology 2006 cited by 2,047

  5. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview

    Authors: Markku Miettinen, Cristina R. Antonescu, Christopher D.�M. Fletcher, AeRang Kim, Alexander J. Lazar, Martha Quezado, Karlyne M. Reilly, Anat Stemmer‐Rachamimov, Douglas R. Stewart, David Viskochil, Brigitte C. Widemann, Arie Perry - Human Pathology 2017 cited by 425

  6. Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies

    Authors: Junko Murai, Anish Thomas, Markku Miettinen, Yves Pommier - Pharmacology & Therapeutics 2019 cited by 170

  7. PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors

    Authors: Maciej Kaczorowski, Małgorzata Chłopek, Anna Kruczak, Janusz Ryś, Jerzy Lasota, Markku Miettinen - The American Journal of Surgical Pathology 2022 cited by 101

  8. Molecular Subtypes ofKIT/PDGFRAWild-Type Gastrointestinal Stromal Tumors

    Authors: Sosipatros A. Boikos, Alberto S. Pappo, J. Keith Killian, Michael P. LaQuaglia, Chris B. Weldon, Suzanne George, Jonathan C. Trent, Margaret von Mehren, Jennifer Wright, J. D. Schiffman, Margarita Raygada, Karel Pacák, Paul S. Meltzer, Markku Miettinen, Constantine A. Stratakis, Katherine A. Janeway, Lee J. Helman - JAMA Oncology 2016 cited by 407

  9. Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal Tumor

    Authors: Jonathan Keith Killian, Su Young Kim, Markku Miettinen, Carly Smith, Maria J. Merino, Maria Tsokos, Martha Quezado, William I. Smith, Mona S. Jahromi, Paraskevi Xekouki, Eva Szarek, Robert L. Walker, Jerzy Lasota, Mark Raffeld, Brandy Klotzle, Zengfeng Wang, Laura Jones, Yuelin J. Zhu, Yonghong Wang, Joshua J. Waterfall, Maureen J. O’Sullivan, Marina Bibikova, Karel Pacák, Constantine A. Stratakis, Katherine A. Janeway, Joshua D. Schiffman, Jian-Bing Fan, Lee J. Helman, Paul S. Meltzer - Cancer Discovery 2013 cited by 355

  10. GATA3

    Authors: Markku Miettinen, Peter A. McCue, Maarit Sarlomo‐Rikala, Janusz Ryś, Piotr Czapiewski, Krzysztof Ważny, Renata Langfort, Piotr Waloszczyk, Wojciech Biernat, Jerzy Lasota, Zengfeng Wang - The American Journal of Surgical Pathology 2013 cited by 683

  11. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline

    Authors: Hedy L. Kindler, Nofisat Ismaila, Samuel G. Armato, Raphael Bueno, Mary Hesdorffer, Thierry Jahan, Clyde Jones, Markku Miettinen, Harvey I. Pass, Andreas Rimner, Valerie W. Rusch, Daniel H. Sterman, Anish Thomas, Raffit Hassan - Journal of Clinical Oncology 2018 cited by 421

  12. Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors

    Authors: Sakshi Tomar, Jingli Zhang, Manakamana Khanal, Jessica Hong, Abhilash Venugopalan, Qun Jiang, Manjistha Sengupta, Markku Miettinen, Nan Li, Ira Pastan, Mitchell Ho, Raffit Hassan - Molecular Cancer Therapeutics 2022 cited by 46

  13. Diagnosis of gastrointestinal stromal tumors: A consensus approach

    Authors: Christopher D.�M. Fletcher, Jules J. Berman, Christopher L. Corless, Fred Gorstein, Jerzy Lasota, B. Jack Longley, Markku Miettinen, Timothy J. O’Leary, Helen Remotti, Brian P. Rubin, Barry M. Shmookler, Leslie H. Sobin, Sharon W. Weiss - Human Pathology 2002 cited by 3,454

  14. Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1–associated atypical neurofibromas

    Authors: Alexander Pemov, Nancy F. Hansen, Sivasish Sindiri, Rajesh Patidar, Christine S. Higham, Eva Dombi, Markku Miettinen, Patricia Fetsch, Hilde Brems, Settara C. Chandrasekharappa, Kristine Jones, Bin Zhu, Jun S. Wei, James C. Mullikin, Margaret R. Wallace, Javed Khan, Eric Legius, Brigitte C. Widemann, Douglas R. Stewart - Neuro-Oncology 2019 cited by 115

  15. KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation

    Authors: Markku Miettinen, Jerzy Lasota - Applied immunohistochemistry & molecular morphology 2005 cited by 550

  16. Gastrointestinal Stromal Tumors of the Stomach

    Authors: Markku Miettinen, Leslie H. Sobin, Jerzy Lasota - The American Journal of Surgical Pathology 2004 cited by 1,249

  17. ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma

    Authors: Markku Miettinen, Zeng-Feng Wang, Anders Paetau, Shyh‐Han Tan, Albert Dobi, Shiv Srivastava, Isabell A. Sesterhenn - The American Journal of Surgical Pathology 2011 cited by 387

  18. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study

    Authors: Bilal Asif, Amber Leila Sarvestani, Lauren A. Gamble, Sarah G. Samaranayake, Amber Famiglietti, Grace‐Ann Fasaye, Martha Quezado, Markku Miettinen, Louis Y. Korman, Christopher Koh, Theo Heller, Jeremy L. Davis - The Lancet Oncology 2023 cited by 58

  19. Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

    Authors: Markku Miettinen, Jerzy Lasota - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2001 cited by 1,861

  20. Gastrointestinal Stromal Tumors: Review on Morphology, Molecular Pathology, Prognosis, and Differential Diagnosis

    Authors: Markku Miettinen, Jerzy Lasota - Archives of Pathology & Laboratory Medicine 2006 cited by 1,453

  21. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)

    Authors: Jerzy Lasota, Markku Miettinen - Seminars in Diagnostic Pathology 2006 cited by 289

  22. Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma

    Authors: Markku Miettinen, Maarit-Sarlomo Rikala, Janusz Ryś, Jerzy Lasota, Zeng-Feng Wang - The American Journal of Surgical Pathology 2012 cited by 109

  23. Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology

    Authors: Markku Miettinen, Zied Abdullaev, Rust Turakulov, Martha Quezado, Alejandro Contreras, Christian A. Curcio, Janusz Ryś, Małgorzata Chłopek, Jerzy Lasota, Kenneth Aldape - The American Journal of Surgical Pathology 2023 cited by 35

  24. Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma

    Authors: Anthony J. Gill, Ondřej Hes, Thomas Papathomas, Monika Šedivcová, Puay Hoon Tan, Abbas Agaimy, Per Arne Andresen, Andrew Kedziora, Adele Clarkson, Christopher W. Toon, Loretta Sioson, Nicole Watson, Angela Chou, Julie Paik, Roderick Clifton‐Bligh, Bruce G. Robinson, Diana E. Benn, Kirsten Hills, Fiona Maclean, Nicolasine D. Niemeijer, Ljiljana Vlatkovic, Arndt Hartmann, Eleonora P.M. Corssmit, Geert J.L.H. van Leenders, Christopher G. Przybycin, Jesse K. McKenney, Cristina Magi‐Galluzzi, Aslı Yilmaz, Darryl C W Yu, Katherine D. Nicoll, Jim Yong, Mathilde Sibony, Evgeny Yakirevich, Stewart Fleming, C.W. Chow, Markku Miettinen, Michal Michal, Kiril Trpkov - The American Journal of Surgical Pathology 2014 cited by 343